Exclusion Criteria:~* The subject is currently taking or has taken a medication for the treatment of
Alzheimer's disease or dementia within 60 days prior to Screening Visit 1~* The subject has a history of any
significant neurologic disease other than AD.~* In the opinion of the investigator, the subject has any
clinically significant uncontrolled medical or psychiatric illness.~* The subject has reported history of
discontinuation of donepezil due to lack of efficacy.~* The subject has a history of intolerance or adverse
reaction to donepezil that led to discontinuation.~* The subject has a known hypersensitivity to donepezil,
piperidine derivatives, or any of the excipients in either donepezil hydrochloride or ABT-126 formulations.~*
Patient uses non-prescribed drugs of abuse or has a history of drug or alcohol abuse/dependence.~* Subjects
with AST and ALT values at Screening Visit 1 that are greater than or equal to 1.5-fold the upper limit of
normal (ULN).
